Skip to main content
OpenTrials

Clinical trial condition

Stage III Colon Cancer AJCC v8

Explore clinical trials studying Stage III Colon Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

13 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Stage III Colon Cancer AJCC v8 trial results

Recruiting

Family Communications After Genetic Testing

NCT07143487

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +25 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 299 locations
View Trial Details
Recruiting

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

NCT07405476

Conditions
Colon Carcinoma, Colonic Diseases, Colonic Neoplasms, +22 more
Locations
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
  • Emory Decatur Hospital Decatur, Georgia, United States
View Trial Details
Recruiting

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

NCT07140679

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +12 more
Locations
  • Emory Decatur Hospital Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View Trial Details
Active, not recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, not recruiting

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

NCT03516942

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +28 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 716 locations
View Trial Details
Active, not recruiting

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

NCT02912559

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +19 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 1049 locations
View Trial Details
Active, not recruiting

Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation

NCT05308446

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +18 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Mercy Cancer Center - Carmichael Carmichael, California, United States
  • Mercy San Juan Medical Center Carmichael, California, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 286 locations
View Trial Details
Active, not recruiting

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

NCT05710406

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +13 more
Locations
  • Beebe South Coastal Health Campus Millville, Delaware, United States
  • Helen F Graham Cancer Center Newark, Delaware, United States
  • Medical Oncology Hematology Consultants PA Newark, Delaware, United States
  • Beebe Health Campus Rehoboth Beach, Delaware, United States
View all 202 locations
View Trial Details

Related conditions